Form 8-K - Current report:
SEC Accession No. 0001213900-24-078783
Filing Date
2024-09-16
Accepted
2024-09-16 10:15:08
Documents
20
Period of Report
2024-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0214504-8k_inmune.htm   iXBRL 8-K 36950
2 FORM OF WARRANT ea021450401ex4-1_inmune.htm EX-4.1 116384
3 OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP ea021450401ex5-1_inmune.htm EX-5.1 14453
4 FORM OF SECURITIES PURCHASE AGREEMENT ea021450401ex10-1_inmune.htm EX-10.1 181236
5 FORM OF PLACEMENT AGENCY AGREEMENT ea021450401ex10-2_inmune.htm EX-10.2 47861
6 PRESS RELEASE, DATED SEPTEMBER 13, 2024 ea021450401ex99-1_inmune.htm EX-99.1 10262
10 GRAPHIC ex5-1_001.jpg GRAPHIC 15784
11 GRAPHIC ex99-1_001.jpg GRAPHIC 3780
  Complete submission text file 0001213900-24-078783.txt   711612

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE inmb-20240912.xsd EX-101.SCH 3018
8 XBRL LABEL FILE inmb-20240912_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE inmb-20240912_pre.xml EX-101.PRE 22361
22 EXTRACTED XBRL INSTANCE DOCUMENT ea0214504-8k_inmune_htm.xml XML 3805
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 241299855
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)